1.11
price down icon2.70%   -0.00
 
loading

Allakos Inc Azioni (ALLK) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
12.44%
73.07
64.98 48.21 37.82 45.05
Operating Income/Loss
12.44%
-73.07
-64.98 -48.21 -37.82 -45.05
Income/Loss From Continuing Operations Before Tax
13.74%
-71.15
-62.55 -45.63 -35.12 -42.40
Income/Loss From Continuing Operations After Tax
13.74%
-71.15
-62.55 -45.63 -35.12 -42.40
Net Income/Loss
13.74%
-71.15
-62.55 -45.63 -35.12 -42.40
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
33,893%
88.04
0.259 87.11 86.65 85.84
Diluted Average Shares
33,893%
88.04
0.259 87.11 86.65 85.84
Basic Earnings Per Share
12.50%
-0.81
-0.72 -0.52 -0.41 -0.49
Diluted Earnings Per Share
12.50%
-0.81
-0.72 -0.52 -0.41 -0.49
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.36
price down icon 1.88%
$72.65
price down icon 0.68%
$23.34
price up icon 5.20%
$370.48
price up icon 0.61%
biotechnology ONC
$215.60
price down icon 1.09%
$116.42
price down icon 0.66%
Capitalizzazione:     |  Volume (24 ore):